Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203. Hematological oncology. 2024. 42. 3. e3272
Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203. British Journal of Haematology. 2023
Kana Miyazaki, Rika Sakai, Noriko Iwaki, Go Yamamoto, Kayoko Murayama, Momoko Nishikori, Kazutaka Sunami, Isao Yoshida, Hiroki Yano, Naoki Takahashi, et al. Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL. Cancer science. 2023. 114. 6. 2689-2691
Yuma Nato, Kana Miyazaki, Hiroshi Imai, Eri Nakano, Yuki Kageyama, Kazuko Ino, Atsushi Fujieda, Takeshi Matsumoto, Isao Tawara, Kyosuke Tanaka, et al. Correction to: Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. International journal of hematology. 2022. 115. 3. 452-453
Kana Miyazaki, Ritsuro Suzuki, Masahiko Oguchi, Senzo Taguchi, Jun Amaki, Takeshi Maeda, Nobuko Kubota, Dai Maruyama, Yasuhito Terui, Nodoka Sekiguchi, et al. Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma. Hematological oncology. 2022. 40. 4. 667-677
Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma. BLOOD. 2022. 140. 3615-3617
Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)
(BLOOD 2022)
Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma
(BLOOD 2022)